A drug development study for a periodontal disease : Biological properties of synthetic lipid A of Porphyromonas gingivalis lipopolysaccharide
牙周病药物开发研究:牙龈卟啉单胞菌脂多糖合成脂质A的生物学特性
基本信息
- 批准号:17592170
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
A pentaacyl and diphosphoryl lipid A molecule (J Bacteriol 1995: 177: 2098) found in the lipid A isolated from P. gingivalis LPS was chemically synthesized, and its characteristics were evaluated to reconfirm its interesting bioactivities including low endotoxicity and activity against LPS-unresponsive C3H/HeJ mouse cells. The synthesized P. gingivalis lipid A (synthetic Pg-LA) exhibited strong activities almost equivalent to those of Escherichia coli-type synthetic lipid A (compound 506) in all assays on LPS-responsive mice, and cells. LPS and native lipid A of P. gingivalis displayed overall endotoxic activities, but its potency was reduced in comparison to the synthetic analogs. In the assays using C3H/HeJ mouse cells, the LPS and native lipid A significantly stimulated splenocytes to cause mitosis, and peritoneal macrophages to induce TNF-D and IL-6 production. However, synthetic Pg-LA and compound 506 showed no activity on the LPS-unresponsive cells. Inhibition assays using some i … More nhibitors including anti-human TLR 2 and TLR4/MD-2 complex monoclonal antibodies showed that the biological activity of synthetic Pg-LA was mediated only through the TLR4 signaling pathway that might act as a receptor for LPS, whereas TLR2, possibly together with CD14, was associated with the signaling cascade for LPS and native lipid A of P. gingivalis, in addition to the TLR4 pathway. These results suggested that the moderated and reduced biological activity of P. gingivalis LPS and native lipid A, including the activity on C3H/HeJ mouse cells by TLR2-mediated pathway, may be mediated by bioactive contaminants or low acylated molecules present in the native preparations having multiple lipid A moieties.In conclusion, these findings suggested that the moderated and reduced biological activity of P. gingivalis LPS and native lipid A, including the activity on C3H/HeJ mouse cells by TLR2-mediated pathway, may be mediated by bioactive contaminants or low acylated molecules present in the native preparations having high heterogeneity in lipid A moiety. To elucidate these problems, we are now attempting to evaluate the biological characterizations of tetra-acylated monophosphorylated or diphosphorylated species with the predominant molecules found in P. gingivalis native lipid A, using each chemically synthesized analog. Less
A pentaacyl and diphosphoryl lipid A molecule (J Bacteriol 1995: 177: 2098) found in the lipid A isolated from P. gingivalis LPS was chemically synthesized, and its characteristics were evaluated to reconfirm its interesting bioactivities including low endotoxicity and activity against LPS-unresponsive C3H/HeJ mouse cells.在LPS响应性小鼠和细胞上的所有测定中,合成的牙龈疟原虫脂质A(合成PG-LA)几乎表现出强大的活性,几乎相当于coli-type合成脂质A(化合物506)的活性。牙龈疟原虫的LPS和天然脂质A显示出总体内毒性活性,但与合成类似物相比,其效力降低了。在使用C3H/HEJ小鼠细胞的测定中,LPS和天然脂质有明显刺激的脾细胞引起有丝分裂,以及腹膜巨噬细胞诱导TNF-D和IL-6产生。然而,合成PG-LA和化合物506在LPS无反发细胞上没有活性。使用某些I…更多的核糖体(包括抗人TLR 2和TLR4/MD-2复杂的单克隆抗体)的抑制作用调查表明,合成PG-LA的生物学活性仅通过TLR4信号传导途径介导,这些信号传导途径可能与LPS的接收器以及CASC相关,而CASC则与CD14相关的接收器,而CD14则可能与CASC相关。除TLR4途径外,牙龈。这些结果表明,在TLR2介导的途径上,通过TLR2介导的途径在C3H/HEJ小鼠细胞上的适度和减少的生物学活性可能是通过生物活性污染物或低酰基化的分子介导的,或在生物学制剂中存在于Moieties and Moieties。 Gingivalis LPS和天然脂质A,包括通过TLR2介导的途径对C3H/HEJ小鼠细胞的活性,可以通过生物活性污染物或在脂质A部分中具有高异质性的天然制剂中存在的生物活性污染物或低酰基化的分子介导。为了阐明这些问题,我们使用每种化学合成的类似物,试图评估四酰化单磷酸化或二磷酸化的物种的生物学特性,其主要分子在牙龈疟原虫天然脂质A中发现的主要分子。较少的
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUMADA Hidefumi其他文献
KUMADA Hidefumi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KUMADA Hidefumi', 18)}}的其他基金
Intranasal immunization of mice with P. gingivalis fimbriae and recombinant cholera toxin B subunit induces strong mucosal and systemic immune responses
用牙龈卟啉单胞菌菌毛和重组霍乱毒素 B 亚基鼻内免疫小鼠可诱导强烈的粘膜和全身免疫反应
- 批准号:
13671919 - 财政年份:2001
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The study of structural factor of lipid A to mediate the activation of C3H/HeJ mice
脂质A结构因子介导C3H/HeJ小鼠活化的研究
- 批准号:
09670301 - 财政年份:1997
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
脂多糖修饰酶EptA对细胞膜脂质相分离的响应机制研究
- 批准号:32301041
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
桑叶多糖与肠道菌群互作产物通过影响肝miRNA调控脂代谢的作用机制研究
- 批准号:32372245
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
超分子作用对脂多糖自组装涂层形态结构演变的多层次调控及多重防污机制研究
- 批准号:52375221
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
脂多糖生物合成基因介导的禽沙门菌对噬菌体抗性进化及权衡机制研究
- 批准号:32373014
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
工程化红细胞胞外囊泡对脂多糖诱导的ALI/ARDS作用及机制研究
- 批准号:82300110
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
水難溶性栄養成分の最適送達に向けた多糖-脂質ナノ複合体の機能設計と食品開発
多糖-脂质纳米复合物的功能设计和食品开发,以最佳地输送难溶性营养成分
- 批准号:
24K00361 - 财政年份:2024
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
多発性硬化症の異なる病型モデルにおける抗糖脂質抗体の役割の解明
阐明抗糖脂抗体在多发性硬化症不同疾病模型中的作用
- 批准号:
24K10163 - 财政年份:2024
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
糖脂質の真の機能を解明する多角的解析プラットフォームの開発
开发多方面分析平台以阐明糖脂的真正功能
- 批准号:
24K08414 - 财政年份:2024
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
真核微生物のGal糖鎖が果たす認識糖としての役割
Gal糖链在真核微生物中作为识别糖的作用
- 批准号:
22KJ2454 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Disrupting Dogma: Investigating LPS Biosynthesis Inhibition as an Alternative Mechanism of Action of Aminoglycoside Antibiotics
颠覆教条:研究 LPS 生物合成抑制作为氨基糖苷类抗生素的替代作用机制
- 批准号:
10653587 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别: